Tuesday, March 26, 2019

#AI Tech News: Peerless-AV To Feature Smart City Kiosk With VSBLTY (CSE: $VSBY.C) CMS & AI-Driven Analytics Software At Digital Signage Expo In Las Vegas

#AI Tech News: Peerless-AV To Feature Smart City Kiosk With VSBLTY (CSE: $VSBY.C) CMS & AI-Driven Analytics Software At Digital Signage Expo In Las Vegas



PHILADELPHIA, PA - March 26, 2019 (Investorideas.com Newswire) The Smart City Kiosk that Peerless-AV will present at the Digital Signage Expo (DSE) March 26-29 will feature state-of-the-art VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) software including VSBLTY's industry-leading VisionCaptor™ and DataCaptor™. The Peerless-AV/VSBLTY collaboration will be on display at Peerless-AV Booth #2407 at DSE 2019, held at the Las Vegas Convention Center. The conference is expected to attract over 4,000 digital signage users, systems integrators as well as advertising and marketing professionals.

VSBLTY is a leading retail software and technology company that provides audience measurement using the power of machine learning through computer vision. Its proprietary VisionCaptor combines brilliantly executed motion graphics or interactive brand messaging on any digital display at point of customer contact with "first of its kind" FacialAnalytics. VSBLTY's measurement technology records engagement rates, interactions, sentiment, and real time behavioral analytics.


Jay Hutton, VSBLTY Co-Founder and CEO, said, "Beyond simply signage, our technology—which uses artificial intelligence combined with machine learning—enables consumers to interact with the display, manipulate content, and engage in a rich, immersive experience through intuitive touch."

In addition, Hutton explained that with this advanced technology message content can be specifically designed for individual viewing based on age, gender, location and day-parts, while at the same time capturing valuable data on consumer traffic, engagement, dwell time and interaction.

Peerless-AV offers a broad array of digital signage solutions from fully interactive kiosks and comprehensive LED deployments to IP68 ruggedized outdoor displays and fully serviceable mounting infrastructure. Peerless-AV's kiosks are designed with superior aesthetics in mind while accentuating the environment in which they are deployed. Nick Belcore, Peerless-AV Executive Vice President, said, "We selected only the very best partners to showcase in our fully integrated kiosk products at DSE. VSBLTY software and VisionCaptor are featured in the Smart City Kiosk at the show because it serves as an ideal example of an extremely powerful tool with a broad array of capabilities that transforms our hardware into a perfectly integrated solution ready to deploy.

Other News
VSBLTY Groupe Technologies Corp. (the "Company") entered into a Financial Advisory Services Agreement (the "Advisory Agreement") with Gravitas Securities Inc. ("Gravitas") dated March 21, 2019 to assist the Company in assessing future business opportunities and developing a capital markets strategy (the "Services").

Subject to the prior approval of the Canadian Securities Exchange (the "CSE") and in consideration for the Services, the Company has agreed to pay to Gravitas a monthly retainer payable by the issuance of an aggregate of 349,992 common shares of the Company at a deemed price of CAD$0.58 per common share to be paid monthly and issued quarterly for a term of twelve (12) months. The term may be extended by mutual agreement of both parties.

The Advisory Agreement and issuance of securities thereunder remains subject to approval of the CSE. Any securities issued pursuant to the Advisory Agreement are expected to be subject to a hold period expiring on the date that is four months and one day from the issuance of the securities.

Investor Relations
Erin Ostrom, 604-219-6648
investor@vsblty.net
CONTACT: Linda Rosanio, 609-472-0877lrosanio@vsblty.net


About VSBLTY (www.vsblty.net)
Headquartered in Philadelphia, VSBLTY (CSE: VSBY) is the world leader in Proactive Digital Display™, which transforms retail and public spaces as well as place-based media networks with SaaS-based audience measurement and security software that uses artificial intelligence and machine learning.

SOURCE VSBLTY

VSBLTY Groupe Technologies Corp. (CSE: VSBY) is a featured Tech / AI stock on Investorideas.com

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Disclosure: VSBLTY is a paid PR, news and social media client on Investorideas.com as of March 1, 2019  https://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp





Monday, March 25, 2019

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Choom (CSE: $CHOO.C), (TSX: $WEED.TO), (NYSE: $CGC), The Green Organic Dutchman (TSX: $TGOD.TO), Newstrike (TSXV: $HIP.V) and Liberty Health (CSE: $LHS.C)


Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Choom (CSE: $CHOO.C), (TSX: $WEED.TO), (NYSE: $CGC), The Green Organic Dutchman (TSX: $TGOD.TO), Newstrike (TSXV: $HIP.V) and Liberty Health (CSE: $LHS.C)



Delta, Kelowna, BC –March 25, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another Investorideas.com “potcast”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we are looking at announcements from  Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF), Canopy Growth Corporation (TSX: WEED), (NYSE: CGC), The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), Newstrike Brands Ltd. (TSX-V:HIP) and Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF).


Choom Holdings Inc., an emerging adult and medical use cannabis company that has secured one of the largest national retail networks in Canada, announced, following its strategy to become a multi-state operator, that it intends to expand into Florida.  Choom, through its wholly owned US subsidiary, Choom Holdings USA Inc., has signed a letter of intent to purchase a 95% equity interest in a Florida-based vertically-integrated cannabis applicant.

The FL Company is progressing on its Master License application to operate up to 25 retail locations with potential for more as the number of registered patients increase, as well as, a micro-processing and cultivation facility for medical purposes. Upon completing the transaction, Choom will use its medical brand, Clarity Medical Centres, to create a network of branded Medical Marijuana Treatment Centers.  Florida's medical marijuana program has over 190,000 qualified patients, up from approximately 168,000 at the start of 2019, making it the largest medical marijuana market in the United States.  Florida has recently allowed the use of smokable medical marijuana products, potentially opening the program to a considerably larger audience.

"We are very excited to be expanding into Florida and to bring Choom's medical brand into that market.  Florida's medical marijuana program is a very attractive opportunity for us seeing that it allows for vertically-integrated operations and it has been a market we've had our sights on for a while now." states Chris Bogart, President & CEO of Choom. "This investment aligns with our strategy of becoming a multi-state operator in the US and helps us to bolster our growth targets. Florida is home to over 21 million residents and has shown impressive year over year growth on the number of registered patients with a large portion of the market being relatively uncaptured."

Canopy Growth Corporation announced that it has received a cultivation license from Health Canada for its facility in Fredericton, New Brunswick. With this licensing, Canopy Growth predicts the facility will initially produce more than 5,000kg of cannabis annually, with first harvests expected to become available to the market within six months.

Developed in collaboration with Canopy Rivers Inc. (TSXV: RIV) and operating under Canopy Growth's flagship Tweed brand, the facility will support the Company's global and local operations with high quality, large-scale cannabis production capabilities that will serve the needs of recreational and medical customers. To meet that demand, Canopy Growth expects to create more than 130 jobs at the Fredericton plant.
         
"New Brunswick has emerged as a leader in the legal cannabis sector and the province is an excellent place to do business," said Bruce Linton, co-CEO and Chairman, Canopy Growth. "We will leverage our existing operational expertise to ensure we support the needs of our customers while making a meaningful contribution to the local economy primarily through new job creation."

The Green Organic Dutchman Holdings Ltd. announced that effective today sales of certified-organic cannabis have started with national distribution to medical patients. The Growers' Circle is a select group of patients across Canada now receiving TGOD's first certified-organic flower. The Growers' Circle launch is a limited production rollout of the Company's premium product, allowing TGOD to perfect its distribution ahead of its production ramp-up and scaled rollout this year.

"The launch of the Growers' Circle is another significant moment in TGOD's commercial story," said Brian Athaide, Director and Chief Executive Officer. "Our certified-organic cannabis is a premium experience for patients. We are proud of our product and excited to be sharing it with Growers' Circle members."

TGOD cannabis is grown in living soil without synthetic fertilizers, pesticides or herbicides. TGOD cannabis is certified-organic by ECOCERT and Pro-cert, pre-eminent global certification bodies. Hill & Knowlton consumer research confirmed that 60% of medical cannabis patients prefer certified-organic product. TGOD flower is packaged in recyclable glass jars and speaks to the Company's product quality, sustainability and regenerative philosophy.

TGOD is now shipping its Unite Organic strain to over 200 medical patients across Canada. "It's been a rewarding experience to get to this point, talking with consumers and understanding their needs, through to growing and cultivating organic product," said Csaba Reider, President of TGOD. "Growing organic requires patience, and we know that our cannabis was worth the wait."

TGOD Growers' Circle members will receive a state-of-the-art online and app experience that provides timely information on individual medical needs. "We have spent months talking with consumers about their preferred cannabis experience," said Andrew Pollock, Vice President of Marketing for TGOD. "We believe that through our website, the experience – from signup to follow-up, to ongoing care - will be the finest in the industry."

Newstrike Brands Ltd. announced that Up Cannabis Inc., its wholly-owned subsidiary, has entered into an agreement with Cannabis NB as a licensed producer to supply cannabis.

"We are very excited to announce this partnership with Cannabis NB," said Jay Wilgar, CEO of both Newstrike and Up Cannabis. "Being among the select group of licensed producers that will supply cannabis to the New Brunswick marketplace is a privilege, and we look forward to helping Cannabis NB achieve its goals of providing safe, reliable product to adult-use consumers."

With this announcement, Up Cannabis becomes one of only eight Licensed Producers that currently supplies Cannabis NB.

Liberty Health Sciences Inc., a provider of high quality cannabis, announced today that it has received Florida Department of Health (DOH) approval to sell whole flower smokable products to patients in Florida, making it one of the first companies in the state to provide smokable medical marijuana in all of its dispensaries. The Company is awaiting DOH approval to provide pre-rolls to patients.

Patients who receive medical marijuana from their doctor will now be able to smoke the substance legally under a bill (SB 182) signed into law last week by Governor Ron DeSantis revoking a ban on smoking medical marijuana. More than 70 percent of voters approved a ballot measure in 2016 legalizing marijuana for medical use, but the Florida Legislature passed a bill a year later that banned it in smokable forms. The new law provides patients the ability to access medicine in the form their doctor determines best for them, whether it's smoking medical marijuana or utilizing other delivery systems.

"This is truly a historic moment not only for Liberty Health Sciences but for the State of Florida," said Victor E. Mancebo, interim Chief Executive Officer of Liberty. "Receiving DOH approval – the same week that Governor DeSantis signed SB 182 allowing patients registered under the Department of Health to smoke medical marijuana – is monumental for Liberty and its ability to offer patients an additional medicinal option. Patients in Florida have been eager for this bill to pass as there is a fundamental need for this medicine in all of its forms."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708


  Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move.  Learn more https://www.investorideas.com/membership/




About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast and news publication  services and costs https://www.investorideas.com/News-Upload/ 
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411










The #AIEye: Veritone’s (NasdaqGM: $VERI) aiWARE Receives FedRAMP Approval and Viome Collaborating with Helomics (NasdaqCM: $AIPT) to Study Cancer with #AI



The #AIEye: Veritone’s (NasdaqGM: $VERI) aiWARE Receives FedRAMP Approval and Viome Collaborating with Helomics (NasdaqCM: $AIPT) to Study Cancer with #AI

AI-Based Chatbot Market to Reach $2.2 Billion by 2024



Point Roberts WA, Vancouver BC – March 25, 2019  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:



Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

AI-Based Chatbot Market to Reach $2.2 Billion by 2024

A new report from Research and Markets indicates that the AI-based chatbot market will reach $2.2 billion globally by 2024. An excerpt from the report summary reads:

Artificial Intelligence (AI) enabled chatbots are taking Customer Relationship Management (CRM) to a new level as business-to-business, business-to-consumer, and consumer-to-business communications is both automated and improved by way of push and pull of the right information at the right time. Chatbots also provide benefits to customers as both existing clients and prospects enjoy the freedom to interact on their own terms. Our research indicates that over 50% of customer queries may be managed today via AI-based chatbots.


Veritone’s aiWARE Receives FedRAMP Approval and Viome Collaborating with Helomics to Study Cancer with AI
Stocks discussed: (NasdaqGM:VERI) (NasdaqCM:AIPT)

Veritone, Inc. (NasdaqGM:VERI) has received Federal Risk and Authorization Management Program (FedRAMP) Authorization for its aiWARE platform. aiWARE is a government platform which “orchestrates an expanding ecosystem of machine learning models to transform audio, video and other data sources into actionable intelligence”. Ryan Steelberg, president of Veritone, said:

“Achieving a FedRAMP Authorization is a huge milestone for Veritone and validates our AI platform as a viable and secure option for federal agencies to leverage artificial intelligence to accomplish their missions more efficiently and effectively. Because our aiWARE Government platform fulfilled the rigorous security requirements to achieve a FedRAMP Authorization, individual agencies can now expedite the procurement and use of our AI offerings.”

Health tech firm Viome has announced a collaboration with Precision Therapeutics Inc. (NasdaqCM:AIPT) company Helomics to study the link between the gut microbiome and ovarian cancer. The study will see Viome’s proprietary microbiome analysis platform and artificial intelligence (AI) platform. Gerald Vardzel, President and CEO of Helomics Corporation, said:

"Helomics pioneered using knowledge gained from drug response and genomic profiling of the patient's living tumor to help individualize ovarian cancer therapy. The collaboration with Viome is groundbreaking, generating data from the microbiome combined with our existing data and using our respective AI platforms, to offer an innovative, holistic and personalized approach to helping oncologists choose the best treatment options for patients with ovarian cancer.”


Sam Mowers, Investorideas.com


For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 
The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, contents creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: More disclaimer info: shttps://www.investorideas.com/About/Disclaimer.asp ,
Learn more about our podcast and article services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

Contact Investorideas.com
800 665 0411



“HOMZ ETF (NYSE: $HOMZ) is the future of real estate investment”


“HOMZ ETF (NYSE: $HOMZ) is the future of real estate investment”


Point Roberts WA, Delta BC – March 25, 2019 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource covering homebuilder and real estate stocks, issues commentary from a recent interview with Alex Pettee, CFA, President of Hoya Capital Real Estate, discussing the new Hoya Capital Housing ETF (NYSE: HOMZ).

Hoya Capital Real Estate is proving that investment doesn’t have to be an alienating concept with their launch of HOMZ, the first exchange traded fund (ETF) to offer diversified investment options throughout the entire US housing industry.

It originally started as a “mock” company as part of an independent study in REIT portfolio management, for a Master's in Real Estate Finance program. Within a half decade, the idea of an accessible investment advising and research company had been built into an institutional platform.

An interview with Alex Pettee, CFA, President of Hoya Capital Real Estate reveals the exciting developments Hoya has made surrounding ETFs in the housing sector.


“HOMZ has been very well received by the market and we've been overwhelmed by the amount of press and investor interest. To our benefit, the housing market is always topical, and we believe that HOMZ is positioned to be the reference barometer for the entire US housing industry in the same way that other major ETFs are used to measure industry performance. The central macroeconomic theme of rising housing costs that HOMZ captures seems to be resonating with younger investors.”

As Pettee puts it, “Hoya Capital Real Estate was founded with the idea of making real estate more accessible to all investors.”

With the housing market in North America being virtually impenetrable for a younger generation of investors he continues to explain how HOMZ can be a powerful strategy.

“We think that HOMZ gives investors, not only millennials but anyone feeling the effects of rising housing costs, an opportunity to get their foot in the door by investing in the companies expected to benefit from rising rents and home values, including many of the companies actually collecting our rent or mortgage checks every month. Younger investors in particular have a strong affinity for ETFs, making it the perfect investment wrapper for HOMZ. We believe that ETFs are one of the greatest financial innovations of the last century because of how truly investor-friendly they are. With HOMZ, you get the liquidity, transparency, and all-day-tradability that is lacking in other platforms and investment vehicles. Plus, it's hard to beat the cost and tax efficiency of ETFs.”

Being a reference barometer for the entire US housing industry is no small job. The amount and type of research that goes into achieving this standard is explained through a keen observation of macroeconomic trends. Restrictive zoning applications and rising costs to build new residential homes, coupled with housing costs exceeding the growth of wages has lead to an under investment of newer developments.

“Meanwhile, the largest “mini-generation” of Americans, the age cohort currently between 25-30 is just now entering the housing markets in full force, creating a perfect storm of factors that is continuing to drive up rents and housing costs. The effect of this underinvestment in residential construction reverberates throughout the industry.”

As the market starts to trend in a positive direction, companies that provide efficient and innovative platforms to enter the housing market are ripe for the moment.

“We believe that HOMZ effectively captures these underlying improvements in efficiency and innovation throughout the sector, but also feel that HOMZ is, itself, part of this innovation.”

Being an integral part of the innovation in this particular space allows for more growth and new ideas. Although the next steps tend to be dictated by the clients and investor’s needs, the company shows no signs of stasis.

“...We have started to roll out our “Real Estate Robo Advisor” platform which uses real estate ETFs to construct portfolios for clients based on their individual investment needs and objectives. Clients’ portfolios are built based on their investment objectives, their risk tolerance, and whether they are an owner or a renter of real estate. We believe that renters, in particular, lack the necessary exposure to real estate and could benefit by increasing their allocation to housing and housing-related assets…”

Through all the impressive developments and innovation that Hoya has already achieved, the original idea of the company rings true as the company hopes to “... eventually become the Wealthfront or Betterment of real estate.”

Interview by Noel Campbell for Investorideas.com

Research homebuilder and real estate stocks at Investorideas.com stock directory

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer and disclosure info: https://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas


Contact Investorideas.com
800-665-0411